Xeris Pharmaceuticals, Inc.

Home » Xeris Pharmaceuticals, Inc.

IPO

Xeris Pharmaceuticals, Inc.

We are a specialty pharmaceutical company leveraging our novel non-aqueous formulation technology platforms, XeriSol and XeriJect, to develop and commercialize ready-to-use injectable and infusible drug formulations.

Symbol

XERS

Price Range
$14.00 - $16.00

Final Shares
5,000,000

Anticipated Date
TBD

Underwriters
Jefferies, Leerink Partners, RBC Capital Markets, Mizuho Securities

To view the prospectus for Xeris Pharmaceuticals, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253